Maxim Group analyst Jason McCarthy initiates coverage on Blue Water Vaccines (NASDAQ:BWV) with a Buy rating and announces Price Target of $4.
Maxim Group Initiates Coverage On Blue Water Vaccines With Buy Rating, Announces Price Target of $4
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.